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The completed sequence and genome organization of OAV287, a serologically distinct ovine adenovirus, is described.
The genome of 29,544 bp has inverted terminal repeats that are only 46 bp in length. Many OAV genes are identified by
their homology with other adenovirus (Ad) sequences but three groups of reading frames show little homology. One group
at the left-hand end of the genome probably represents the E1A/E1B regions. Two others, on the complementary strand
at the right-hand end of the genome, are tentatively proposed as the E4 and E3 regions. They are separated by 1 kb of
A/T-rich sequence of unknown function with E3 being adjacent to the terminus. Structural proteins V and IX of human Ads
are absent from the OAV genome but a new, processed, 28-kDa virion polypeptide is encoded on the strand complementary
to the proposed E1A region. The coding sequences for two other structural proteins are unidentified. The OAV penton
protein lacks the region containing an Arg/Gly/Asp sequence that, in human adenoviruses, is thought to interact with cellular
integrins to facilitate virus entry. Analysis of proteins and peptides in purified OAV identified several cleavage sites utilized
by the Ad proteinase. Some of these were previously identified in human Ad proteins, but new sites, some of which did not
conform to the known specificity of the human Ad proteinase, were also identified. The data emphasize that this ovine virus
differs significantly from other known human and animal adenoviruses. q 1996 Academic Press, Inc.
INTRODUCTION et al., 1996). Animal adenoviruses have been isolated
from a variety of species (Ishibashi and Yasue, 1984)
Adenoviruses (Ad) of many serotypes are commonly and, although most of these isolates have been only
found in humans where they can cause a variety low- partially characterized, the basic genome organization
grade diseases in otherwise healthy individuals (Horwitz, and the identity of the structural proteins appears to be
1990b). Several human Ads are well studied at the molec- conserved (Raviprakash et al., 1989; Dragulev et al., 1991;
ular level. The genomes of human Ads 2, 5, 12, and 40 Elgadi et al., 1993; Mittal et al., 1993; Salmon and Haj-
have been completely sequenced (Akusjarvi et al., 1984; Ahmad, 1994; Kleiboeker, 1995; Reddy et al., 1995).
Alestrom et al., 1984; Roberts et al., 1984; Davison et al., We have been studying an ovine adenovirus isolate
1993; Sprengel et al., 1994), revealing that these viruses OAV287 (OAV) which was isolated from sheep in Western
have a similar organization of genes and proteins, most Australia (Peet et al., 1983). Partial nucleotide sequenc-
of which are clearly recognizable as homologues. As a ing clearly identified OAV genes which encoded homo-
large amount of information concerning gene function is logues of structural proteins found in other Ads, but dis-
also available, certain Ads have attracted considerable tinct differences in the OAV genome organization were
interest as vectors for gene therapy and vaccination (re- also revealed (Vrati et al., 1995, 1996a), suggesting that
viewed in Imler, 1995; Smith, 1995; Vigne et al., 1996). further characterization was warranted. Here we de-
Two potential problems affecting such studies have been scribe the sequence and organization of the remainder of
considered. The first involves the possibility of adventi- this genome which, at 29,544 bp in length, is the shortest
tious recombination between the defective therapeutic known among Ads. As this genome has features which
virus and a related replication-competent virus. The sec- are so far unique, molecular studies might be necessary
ond is the presence of preexisting neutralizing antibodies to probe the structure and function of particular genes
to the therapeutic virus due to the prevalence of Ads in and to adapt the virus as a vector. Initial studies in this
the human population. Therefore consideration is being regard are described in an accompanying paper (Vrati
given to the use of viral vectors from other sources (Vigne et al., 1996b).
MATERIALS AND METHODS
1 Present address: National Institute for Immunology, JNU Campus, Virus growth and DNA preparation
New Dehli, 110 067, India.
Procedures for the growth of OAV in CSL503 cells,2 To whom correspondence and reprint requests should be ad-
dressed. its purification by CsCl gradient centrifugation, and the
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TABLE 1
N-Terminal Sequence of Proteins and Peptides of OAV and Ad5
HPLC peak Sequence determined Sequence predicted from genome Peptide or protein identity
OAV
Pyridine R/SI L V P/S P E/S D N/K SILVSPSDN pVII–N-terminus
Pyridine GIGTSS MRA GIGTSS MRAT pVII–peptide II
Pyridine GSNRLT SYPDIP GSNRLT SYPDIP PILK pVIII–peptide IIa
Ad5
Bicarbonate GLRFPS KMF(Q) GLRFPS KMFG pVII–peptide II
Bicarbonate RRAHHR RRRAS HRR GMRRAH HRRRRA SHRR pX–peptide II
OAV protein
1 YFALWNQAVDSY YFALWNQAVDSY Hexon–tryptic peptide
1 LHPDAHYIEY LHPDAHYIEY Hexon–tryptic peptide
7 AYRKRK KKFQRP KPR AYRKRK KKFQRP KPRK p28K–mature protein
9 GLKFSK KQPVRV RPYYRAQ GLKFSK KQPVRV RPYYR pVII–mature protein
10 KVVHV LKSPH/F/K/RRR MKVVHV LKSPHR RRHT pX–N-terminus
a Equivalent to Ad12 pVIII–peptide III (Freimuth and Anderson, 1993).
preparation and cloning of viral DNA have been de- GenBank. The sections and their Accession Nos. are
bases 1–3064, U40839 (probable E1A and E1B regions);scribed previously (Pye, 1989; Boyle et al., 1994). Human
Ad5 was grown in 293 cells and purified as previously bases 3061–9360, U31557 (the IVa2, DNA polymerase,
and terminal proteins) (Vrati et al., 1996a); bases 9141–described (Graham and Prevec, 1991).
19,210, U40837 (coding for the region from 52/55 kDa –
Nucleotide sequencing DBP); bases 19,140 to 23,906, U18755 (coding for 100K
hexon assembly protein to fiber protein) (Vrati et al.,Nucleotide sequences were determined on both
1995); bases 23,851–29,544, U40838 (coding for proba-strands of the genome, initially by generating clones us-
ble E4, A/T-rich, and E3 regions). The complete genomeing a double-stranded nested deletion kit (Pharmacia)
arrangement is summarized in Fig. 1. The base composi-and later by synthesizing oligonucleotide primers ac-
tion is T, 32%; C, 18.2%; G, 15.4%; and A, 34.4%.cording to the newly determined sequence (Vrati et al.,
1995). Sequences were determined manually (Sanger et
Inverted terminal repeats (ITRs)al., 1977) and by using an Applied Biosystems (Foster
City, CA) DNA sequencer.
The ITRs of OAV are 46 nucleotides in length. This is
about one-third to one-quarter of the length of ITRs inPeptide and protein sequencing
other Ads and 6 nucleotides shorter than described for
OAV proteins present in CsCl-purified virions were
an avian Ad which previously had the shortest ITR (Shini-
separated by electrophoresis on a 15% SDS polyacryl-
gawa et al., 1987). The TAAT sequence conserved be-
amide gel and blotted onto PVDF membrane [ABI Problott
tween nucleotides 10 and 13 in other ITRs (Shinigawa et
membrane using 10 mM CAPS buffer (MeOH 10%,
al., 1987) is not conserved in OAV, but an AT dinucleotide
0.025% SDS, pH 11.0]. The proteins on the membrane
redundancy, which may be involved in the regeneration
were stained with 0.1% Coomassie R250, destained, and
of termini during DNA replication (Graham et al., 1989),
then washed with several changes of deionized water.
is present between bases 7 and 14. The ITRs in human
Aldehyde-free acetic acid (BDH) was used in both the
Ads bind a variety of cellular transcription factors which
stain and the destain steps. Each protein was excised
stimulate the initiation of DNA replication (Hatfield and
from the PVDF membrane and sequenced on a Hewlett –
Hearing, 1993, and references therein). Within the shorter
Packard G1000A protein sequencer. Peptides were ex-
ITRs of OAV, only a binding site for SP1 is recognizable
tracted from purified OAV with pyridine or bicarbonate
within the GC-rich region between bases 28 and 36.
as previously described (Freimuth and Anderson, 1993)
and separated by HPLC before sequencing. Eight peaks
OAV E1A and E1B regionsin the bicarbonate fraction and 17 in the pyridine fraction
were resolved. All were sequenced but only a few yielded The left-hand end of the OAV genome contains open
meaningful data (Table 1). reading frames (ORF) identified as 7.9, 12, 14.7, p28, and
42.8 kDa, according to size (Fig. 2). Other smaller ORFs
RESULTS AND DISCUSSION which contain 5*-proximal Met codons exist upstream of
the 7.9-kDa ORF. In other adenovirus genomes, the left-The complete sequence of the OAV genome (29,544
bp) has been determined and submitted in sections to hand end codes for the E1A and E1B families of proteins
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FIG. 1. Organization of the OAV genome. Genes are named as homologues of Ad2 except for p28K and the A/T-rich region which are unique.
Proposed early region genes are italicized. The identification of regions E1A/B, E3, and E4 is tentative because of limited homology with other Ad
sequences. Thick lines show the position of the ORFs for the polypeptides indicated. Thin lines indicate the probable extension of transcripts to
polyadenylation signals (*) at the ends of ORFs.
which are encoded by transcripts produced by differen- quences. The 14.7-kDa ORF shows very low level identity
with E1B 19-kDa homologues from variety of human andtial splicing of RNAs derived from separate promoters
(reviewed in Horwitz, 1990a). The 7.9- and 12-kDa ORFs animal Ads (Fig. 3A). The human Ad E1B 19-kDa protein
is thought to be functionally similar to the apoptosis-lack 5* methionine codons but are positioned in the ge-
nome such that they could be spliced to code for OAV inhibiting Bcl-2 protein and limited homology can be de-
tected between them (Boyd et al., 1994; Chiou et al.,E1A products. It seems likely that transcripts incorporat-
ing these ORFs would terminate at the AATGAA polyade- 1994). However, the motifs identified are poorly con-
served in the OAV 14.7-kDa ORF. Similarly, the 42.8-kDanylation signal at the 3* end of the 12-kDa ORF (Vrati et
al., 1995). ORF shows low-level identity with the E1B large T protein
from a variety of human and animal Ads (Fig. 3B) and isSequences of predicted OAV proteins were compared
with their homologues from other human and animal Ads, tentatively suggested to be the OAV counterpart.
The unique feature of this region of the OAV genomeas features that are conserved between viruses from
diverse species may indicate functional significance. The compared with other Ads is the presence of a new ORF
on the right-to-left strand (Fig. 2) which is predicted to7.9- and 12-kDa ORFs show little homology with other
Ad sequences, even at the amino acid level. The 249- code for a protein with a maximum size of only 21.5
kDa (177 residues) if initiation occurs at the 5*-most Metresidue E1A protein homologue of other Ads contains
the highly conserved motif C-X2-C-X13-C-X2-C-Y-L/M codon. However, it actually codes for a virion structural
protein with an apparent size of 28 kDa under denaturingwhich encodes a zinc finger motif in its trans-activating
domain (Culp et al., 1988). This motif is not recognizable conditions on SDS–PAGE (Fig. 4). This protein was iden-
tified by N-terminal sequencing which also revealed thatin the OAV genome, although the 12-kDa ORF contains
a C-X2-C-X12-C-X3-C sequence. the protein is synthesized as a precursor, cleavage oc-
curring at type I cleavage sequence, LAGG*AYR (TableThe OAV E1B region could code for proteins of 14.7
and 42.8 kDa as each of these ORFs has a 5*-proximal 1), to produce a mature protein of 129 residues with a
charge of /18 and a predicted size of 15.5 kDa (Fig. 5).Met codon. Each ORF also has a polyadenylation signal
near its 3* end, suggesting that transcription may be The protein shows no recognizable homology with any
other gene in the databases. The genomic location ofterminated independently. The termination site of tran-
scripts encoding the 42.8-kDa ORF have been mapped p28K ORF also suggests that it may be under the control
of its own promoter, which could be located between theto bases 3101–3103 and 3110 (Vrati et al., 1996a). The
8.9-kDa ORF (Fig. 2) does not have a Met codon and 12- and the 14.7-kDa ORFs (Fig. 2). Other Ads also have
an ORF near the end of E1B which codes for protein IX,may not be used unless it is spliced to upstream se-
FIG. 2. Genome arrangement at the left-hand end of OAV. ORFs are named according to the size of the protein they could encode, except for
p28K which encodes a protein of apparent size 28 kDa. (l) 5*-proximal Met codon in the ORF. The thin line for p28K indicates a probable extended
transcript. (*) Likely polyadenylation signal.
AID VY 7912 / 6a17$$$422 05-06-96 10:12:19 vira AP: Virology
189OVINE ADENOVIRUS GENES AND PROTEINS
which is a minor capsid component (Furcinitti et al., 1989; The OAV pIIIa ORF is 70 residues shorter due pri-
marily to an N-terminal deletion, but other minor inser-Stewart et al., 1991) and is transcribed from its own pro-
moter (Fire et al., 1981). No such ORF appears to be tions/deletions occur within the protein. Based on its
expected size and relative amount in virions, protein IIIapresent in this location in the OAV genome. Sequences
coding for the IVa2, DNA pol, and terminal proteins as is assigned as band 2 (Fig. 4). However, no sequence
could be determined to confirm this, presumably as thewell as the major late promoter (MLP) and tripartite lead-
ers are described elsewhere (Vrati et al., 1996a). N-terminus is blocked. IIIa is produced as a precursor
in other Ads (Boudin et al., 1980), being cleaved at a
Late viral protein region type II site (LGGS*G) 19 residues from the C-terminus
(Freimuth and Anderson, 1993). This site is not strictlyIn human Ads, late RNA transcripts derived from the
MLP share a common tripartite leader sequence (TLS), conserved in OAV IIIa but a type I site (LIGH*G) is present
20 residues from the C-terminus. However, as no peptideand groups of transcripts (L1–L5) share common polyad-
enylation signals (reviewed in Horwitz, 1990a). Inspection which gave the predicted sequence was isolated from
purified virus, it is unclear whether or not the site is used.of the nucleotide sequence shows that there are a limited
number of appropriately placed polyadenylation signals Penton (III) protein. There is a significant degree of
homology between OAV and Ad2 penton proteins, sug-(Fig. 1). Three of these occur at the ends of the ORFs for
52/55K, pIIIa, pVII, and endopeptidase. The penton, X, gesting that they have a broadly similar structure. The
OAV protein is much shorter (Table 2) due to an N-termi-pVI, and hexon ORFs lack such a signal. It is likely that
52/55K and pIIIa transcripts terminate independently nal truncation and an internal deletion relative to other
penton proteins. Its predicted size (51 kDa) is consistentwhile transcripts for III (penton) and pVII share the poly-
adenylation signal at the end of ORF pVII. The X, pVI, with the tentative assignment of band 4 as penton protein
(Fig. 4). A large helix-turn-helix structure which is pre-and hexon transcripts appear to use the signal at the
end of the 23K endopeptidase ORF (Fig. 1). Similarly, dicted to exist in the Ad2 molecule and which carries an
RGD motif is totally missing in OAV (Fig. 6). The RGDDNA-binding protein (DBP) has an AATGAA sequence at
the 3* end of its ORF which would terminate transcripts motif is thought to interact with cellular integrins, facilitat-
ing virus entry by endocytosis (Wickham et al., 1993;prior to the ORF for endopeptidase which occurs on the
left to right strand (Fig. 1). The signals at the ends of Mathias et al., 1994). While the extended helical domain
is prominent in Ad2, in other Ads the domain is muchpVIII and fiber are also used (Vrati et al., 1995).
Junctions between the OAV TLS and transcripts for the shorter (9–17 residues) and poorly conserved (e.g., Ad40
residues 296–312, Fig. 6). The RGD motif is conserved52/55K and pIIIa proteins have been determined using
RT-PCR (Vrati et al., 1995). The TLS does not contain an in most, but not all human Ads (Bai et al., 1993; Mathias
et al., 1994), while the avian Ad FAV-10 carries a shortATG codon (Vrati et al., 1996a). The splice junction for
52/55K mRNA maps 3* to base 9158, adjacent to the first sequence in this region which differs significantly (Shep-
pard and Trist, 1992; Bai et al., 1993). Although the flank-ATG codon, while that for pIIIa is located 3* to base
10,099, 217 nucleotides upstream of its ATG. The pTP ing sequences in OAV (e.g., residues 224–257 and 257–
308, Fig. 6) show good homology with other Ads, theand 52/55K ORFs overlap by at least 39 codons. This is
significant as in Ad2 the intergenic region between the RGD domain is apparently absent, raising questions as to
whether an interaction between OAV penton and cellularpTP and 52/55K ORFs is occupied by the VA RNA genes
I and II. VA genes appear to exist in OAV but they show integrins can occur, whether such an interaction is re-
quired for entry of OAV into CSL503 cells, and whetherno obvious sequence homology and are located else-
where in the genome (A. Venktesh and G.W.B., unpub- OAV would be capable of infecting human cell types
where such an interaction is apparently required (Wick-lished results).
To obtain biochemical support for events predicted ham et al., 1993, 1994). In addition, the human Ad and
OAV fiber proteins differ completely in their cell-bindingbelow OAV was purified and its polypeptides were sepa-
rated by SDS–PAGE (Fig. 4) or peptides were extracted domains (Henry et al., 1994; Vrati et al., 1995) and pre-
sumably recognize distinct receptors. Nevertheless, re-and separated by HPLC (Freimuth and Anderson, 1993).
Each protein or peptide was subjected to N-terminal se- cent work indicates that OAV can infect certain human
cell types despite these differences (A. Khatri et al., un-quencing, but not all produced meaningful data (Table
1), presumably because the N-terminus was blocked. published results).
Core protein pVII. The ORFs for OAV penton and pVII52/55K and pIIIa proteins. The L1-52 and 55K proteins
are related phosphoproteins which are derived from a overlap but the initiation codon for pVII occurs down-
stream of penton coding sequences. The pVII ORF of48-kDa precursor and appear to be involved in virion
assembly (Hasson et al., 1992). The OAV 52/55K ORF is OAV is considerably smaller than those from human or
canine Ads which are 199 and 132 residues, respec-shorter than in Ad2 (Table 2), principally due to a large
C-terminal deletion. Nevertheless, a cluster of negatively tively (Cai and Weber, 1993b) but larger than the homo-
logue from the avian adenovirus (CELO) (GenBank Ac-charged residues is conserved at the C-terminus.
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FIG. 5. Sequence of the p28K ORF. The cleavage site is indicated
(l). Heavy and light shading identify basic and acidic residues, respec-
tively.
FIG. 4. Separation of OAV proteins in purified virions by preparative
SDS –PAGE. Lane 1, OAV proteins. Lane 2, marker proteins of the
sizes indicated. Proteins were stained with Coomassie blue. Those peptide (SILVSPSDN) and the adjacent peptide GIGTSS-
with question marks are tentatively identified. MRA were also present in the pyridine soluble fraction
extracted from OAV (Table 1). Peptide II (GLRFPSKMF)
was also recovered from the bicarbonate extract of Ad5cession No. Z48167) which is only 72 residues in length
(Fig. 7). The degree of amino acid sequence conservation virions (Table 1). The equivalent peptide was not reported
for Ad12 virions (Freimuth and Anderson, 1993). This sug-between Ad VII proteins decreases sharply beyond about
residue 50. Between residues 26 and 41 in Ad2 a series gests that in OAV and other human Ads an additional
cleavage event may occur at the site NTGW*G duringof basic amino acids occurs whose arrangement shows
similarities with histone proteins (Sung et al., 1983; Cai pVII maturation. This sequence is located at the C-termi-
nal end of the highly conserved N-terminal peptide (Fig.and Weber, 1993b). This may be consistent with the pro-
posed function of the protein in packaging the viral DNA. 7). Although the functional significance of this cleavage
event remains to be determined, clearly in some contextsAlthough OAV protein VII contains numerous basic resi-
dues in this region, they do not conform to spacing of the proteinase cleavage sites of the type (N/M/L/
I).X.G.X.*G or (M/L/I).X.A.X*G are also recognized. Se-the histone-like motifs described above. The identity of
mature protein VII (band 9, Fig. 4) was confirmed by N- quence conservation and the new cleavage event de-
scribed here suggest that the N-terminal region of pVIIterminal sequencing (see below) (Table 1). Its apparent
size on the preparative gel (14 kDa) is unexpectedly may be more important for function than distal se-
quences, many of which appear to be dispensable inhigh compared with the size predicted for the mature
protein (10.5 kDa). some viruses (Fig. 7).
Protein X. OAV protein X is similar in size (Table 2)Two other features of OAV pVII are notable. First, its
N-terminal 16 residues are highly conserved between and homologous to related Ad proteins in its C-terminal
region, suggesting that this portion may be functionallyviruses of human, animal, and avian origin (Fig. 7). Sec-
ond, pVII ORF does not predict that the protein should important. There is little homology in the N-terminal re-
gion although it contains many positively charged resi-be produced from a precursor. According to the known
specificity of Ad proteinases, which recognize cleavage dues which are typically found here in other Ad proteins
(Fig. 8). Sequence alignments show that protease cleav-sites of the type Hy X.G.X.*G or Hy.X.G.G.*X, where Hy is
Leu, Ile, or Met and X is any amino acid (Webster et al., age sites which are present in human Ads 2 and 12 at
residues 32 and 27, respectively (Weber and Anderson,1989; Anderson, 1990), there is no cleavage site at resi-
due 25 in OAV, although the site MYGG*A is used in 1988; Freimuth and Anderson, 1993), are not present in
OAV (Fig. 8). Another potential cleavage site at residueAd12 (Freimuth and Anderson, 1993) and conserved in
the human, canine, and CELO viruses. However, se- 42 of Ad12, which is also conserved in other Ads (Fig.
8) is not used in OAV as no peptide with the sequencequencing of OAV protein 9 (Fig. 4) and peptides (Table
1) revealed that unexpected cleavage events occur in this expected for the C-terminal fragment was recovered from
virions. This may be because in OAV the P1* residue isregion. Structural protein 9 had an N-terminal sequence
GLKFSKKQPRVR (Table 1). Thus, the pVII sequence Phe, which has a large aromatic sidechain. A reduction
in the rate of cleavage of a terminal protein precursor toMRAT*G was recognized by OAV proteinase although
this site does not conform to the specificity previously an intermediate form was observed even when Val was
present in the P1* position (Webster et al., 1994). Thedescribed for human Ad proteinases (Webster et al.,
1989; Anderson, 1990). In addition the pVII N-terminal proposed lack of cleavage of OAV protein X is consistent
FIG. 3. Alignment of homologues of the human and animal Ad E1B (A) 19-kDa and (B) 55-kDa proteins. Sequences from human Ads 2, 12, and
40, and simian, tupaia tree shrew, murine, and OAV sequences were aligned as indicated using the program Seqvu (Garvan Institute, Sydney,
NSW).
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TABLE 2
Comparison of OAV Proteins with Ad2 Homologues
ORF size
Protein OAV Ad2 % similarity a % identity a
52/55K 335b (38.2)c 416 (47) 50 27
pIIIa 515 (58.4c/55.9d) 586 (65.3) 52.7 33
Fiber 543 (58.2) 581 (61.7) 46.2 26.2
III (penton) 452 (51) 572 (63.2) 71 55
pVII 111 (12.9/10.5) 199 (22) 56 36
X 71 (7.8) 80 (8.8) 60 42
pVI 221 (24.5/23.1e) 251 (27) 48 26
II (hexon) 912 (103) 968 (109) 68 53
23-kDa protease 201 (23.2) 205 (23) 58 40
DBP 382 (43.5) 530 (59) 53 31
pVIII 218 (24.7 to 13.2 / 11.4f ) 227 (24.7) 48 32.5
IVa2 446 (51.2) 449 (50.8) 58 39.5
DNA pol 1071 (125.3) 1198 (135.7) 63.8 44.7
Terminal protein 641 (74.7) 672 (76.5) 57.6 33.4
a Comparisons were made using the GCG Bestfit program using a gap weight of 3.0, length weight of 0.1, average match of 0.54, and average
mismatch of 00.396 as parameter settings.
b Number of amino acids.
c Size in kilodaltons.
d Size of mature protein in kilodaltons.
e C-terminal peptide cleavage only.
f Products of cleavage at peptide III site only.
with its identification by N-terminal sequencing (Table 1) al., 1995) and OAV. Surprisingly however, no peptide with
the expected sequence was detected in OAV. Either theas a protein with an apparent size of approximately 10
kDa on an SDS–polyacrylamide gel (Fig. 4). peptide was missed for some technical reason (in analy-
ses of two virus preparations) or it remained attached toProtein pVI. The assignment of band 8 as OAV protein
VI (Fig. 4) agrees with its predicted size (Table 2). The protein VI. The MAV sequence is more closely related to
the human Ad sequences than is OAV. The OAV peptideOAV polypeptide is predicted to be shorter than the Ad2
protein and shows low homology with it (Table 2). Never- is GVNFNTRRYCY. This sequence is only partly identical
with Ad2, but the penultimate Cys, which is thought to betheless, a type I proteinase cleavage site (L/M.X.GG*A)
is conserved about 30 residues from the N-terminus in required for peptide dimerization and protease activation
(Webster et al., 1993), and 2 of 3 Arg residues are con-OAV and most other Ad proteins (Akusjarvi and Persson,
1981; Freimuth and Anderson, 1993) but, as Phe rather served (underlined). The equivalent Ad2 C-terminal pep-
tide is GVQSLKRRRCF. A truncated peptide KRRRCF didthan Ala occupies the P1* position at OAV residue 29,
again the site may be masked. As no sequence data not activate recombinant proteinase (Webster et al.,
1993). As residues 3–6 of OAV and MAV have no homol-could be obtained for band 8 the N-terminus may be
blocked. Near the C-terminus, a type II cleavage site that ogy with each other and the Val at position 2 is not
conserved in MAV, this suggests that the consensus se-is used to generate an 11-residue peptide cofactor for
Ad proteinase (Mangel et al., 1993; Webster et al., 1993) quence required for activity is G.XXXXX.R.R.y/r.C.f/y.
Hexon protein. OAV hexon (band 1, Fig. 4) is the mostis also conserved in mouse adenovirus (MAV) (Song et
FIG. 6. Comparison of human Ad, OAV, and avian Ad penton proteins in the region containing the RGD motif (overlined). Sequence identity is
indicated by boxed shading. Note the absence of the RGD and flanking sequences in OAV.
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FIG. 7. Comparison of OAV protein VII with homologues from the canine Ad, avian Ad (CELO), and human Ads 2, 12, and 40. (l) Cleavage sites
determined experimentally in Ad12 (Freimuth and Anderson, 1993), Ad5, or OAV.
abundant protein in the capsid. It is similar in size to Ad2 and the animal Ads (Hu et al., 1984; Athappilly et al., 1994;
Weber et al., 1994). The OAV l4 sequence is longer by 9hexon but more distantly related to it (Table 2) than the
bovine Ad3 and mouse Ad1 sequences which show 67 residues and appears to be species specific (Fig. 9). Given
this variation in the surface loops of OAV hexon, it isand 66% identity, respectively (Hu et al., 1984; Weber et
al., 1994). Variability between hexon proteins derived from unlikely that there would be any immunological cross-
reactivity between OAV and other Ads. Indeed, OAV287viruses of distinct serotypes is confined largely to external
loops of the protein defined as l1 (Ad2 residues 151–334), appears to be serologically distinct among ovine and bo-
vine adenoviruses (Adair et al., 1986; Boyle et al., 1994).l2 (residues 406–569), and l4 (residues 788–883) (Hu et
al., 1984; Pring-Akerblom and Adrian, 1993; Athappilly et Overall, however, the structure of the OAV hexon must be
broadly similar to that determined for Ad2 (Athappilly etal., 1994; Weber et al., 1994). Loop l3 (residues 699–729)
is well conserved except for a few residues. Loop l1 is al., 1994) as the sequence elements required to stabilize
the structure are well conserved, e.g., only 5 of 26 intramo-considerably shorter in the OAV, murine Ad1, and bovine
Ad3 proteins, partly because the highly acidic region (resi- lecular salt bridges are not directly conserved. In addition,
because it is the major component, the hexon subunitdues 134–163) in Ad2 is absent in the animal viruses (see
Fig. 3 of Weber et al., 1994). Loops l1 and l2 which are may largely determine the size of the icosahedral viral
capsid. As the OAV hexon is only 57 residues shorter thanpoorly defined in the crystallographic model (Athappilly et
al., 1994) contain residues 281–292 and 441–455 which its Ad2 counterpart, principally in the nonhomologous loop
regions, and the OAV genome is small (29.5 kb), this maywere previously shown to react with type-specific neu-
tralizing antisera (Toogood et al., 1992). As expected, there account for the observation that OAV can package a
greater relative proportion of its genome. Ad2, with a ge-is major sequence variation between OAV and other
hexon proteins in these regions and in the vicinity of the nome of 35,937 bp, can only package DNA up to105%
of its size (Bett et al., 1993), while OAV can package atloop l1 epitope the number of residues also varies (Fig.
9). This is consistent with the observation that foreign least 114% (Z. Z. Xu and G.W.B., unpublished results).
Viral proteinase. The OAV endopeptidase ORF over-sequences can be inserted into this site without destroy-
ing virus viability (Crompton et al., 1994). Loop l4 (Ad2 laps the hexon ORF by 4 nucleotides but is separated
from the DBP ORF on the complementary strand by 27residues 823–871) is well conserved among human Ads
but part of it shows great variability between the human nucleotides. The Ad enzyme is a thiol proteinase which
FIG. 8. Comparison of OAV protein X with Ad12, Ad2, and Ad40 homologues. Cleavage sites used in Ads 2 and 12 are indicated (l).
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FIG. 9. Comparison of hexon loop 1, loop 2, and loop 4 regions for Ad2, OAV, bovine Ad3, and murine Ad1. Ad2 sequences which were shown
to react with type-specific neutralizing antisera (Toogood et al., 1992) are overlined.
is essential for virion maturation and infectivity (Mangel ucts of 13.2 and 11.4 kDa might have been expected in
the virus particles. However, none were detected (Fig.et al., 1993; Webster et al., 1993). OAV endopeptidase is
similar in size but its homology with the Ad2 enzyme 4), possibly because they were not resolved from pro-
teins VII and X and the greater amounts of the latter(Table 2) is considerably lower than observed for other
endopeptidases (Cai and Weber, 1993a). However, resi- proteins may have obscured any N-terminal sequence
data from the cleaved polypeptides. The 100K hexon as-dues 54 (His) and 104 (Cys), which are critical for activity
(Grierson et al., 1994; Rancourt et al., 1994), and all resi- sembly, 33K, and fiber proteins have been discussed
previously (Vrati et al., 1995).dues but 1 (Tyr 89 of Ad2) which are conserved between
proteases from other Ads (Vos et al., 1988; Cai and We- New proteins. The surprising feature to emerge from
this analysis of OAV was the discovery that ORFs forber, 1993a) are also conserved in OAV. Thus, the broader
specificity described here for the OAV enzyme may apply proteins V and IX were not found in the expected loca-
tions in the genome. Protein V is normally situated be-more generally to Ad proteinases. Consistent with this,
peptide II of protein VII was found in both OAV and Ad5 tween ORFs for VII and X while protein IX is found at the
3* end of the E1B region (reviewed in Horwitz, 1990a).virions (Table 1).
Protein pVIII. Analysis of OAV peptides also revealed As the other OAV structural proteins were easily identi-
fied by homology searches, it is assumed that proteinsthe presence of a peptide equivalent to peptide III of
pVIII (Freimuth and Anderson, 1993; Vrati et al., 1995) V and IX do not exist in OAV. However, gel analysis
revealed the presence of at least 10 polypeptides in puri-(Table 1), confirming that at least one of two possible
cleavage sites in the OAV protein is used. On the basis fied OAV particles (Fig. 4). Many of these must corre-
spond to structural proteins for which ORFs were found,of this single cleavage event in OAV, pVIII cleavage prod-
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i.e., hexon, penton, IIIa, fiber, VI, VII, VIII, and X. Analysis types and is involved in the determination of host range
(reviewed in Horwitz, 1990a). The C-terminal domain isof tryptic peptides derived from protein 1 (Table 1) con-
firmed that this is the hexon protein. As no sequence more highly conserved and functions in DNA binding,
replication, and the transcriptional activation of the viraldata were obtained for some proteins, presumably be-
cause the N-terminus was blocked, polypeptides with MLP (Zijderveld et al., 1994). Essentially all the homology
between the OAV and the Ad2 proteins (Table 2) liesquestion marks are tentatively identified (Fig. 4). The fiber
and pIIIa proteins were assigned on the basis of the within the C-terminal domain as the N-terminal region is
totally absent from OAV DBP (Fig. 10). OAV DBP (53%relative amounts of the respective polypeptides even
though their expected sizes (Table 2) suggest the reverse similarity and 31% identity to Ad2) represents the most
different DBP described so far, e.g., Ad40 and Ad2 shareorder.
Apart from the newly described p28K protein there are 76% similarity and 61% identity in their C-terminal re-
gions.two other proteins in virus particles (Fig. 4, bands 5 and
6) whose apparent sizes do not match those expected Ad5 DBP is a nuclear phosphoprotein which carries a
bipartite nuclear localization signal PPKKR and PKKKKKfor known structural proteins (Table 2), even if proteolytic
processing is considered. The42-kDa protein 5 consis- between residues 42 and 46 and 84 and 89, respectively
(Cleghon et al., 1989; Morin et al., 1989). Other humantently appeared in CsCl-purified virus preparations (the
40-kDa band was not always resolved) and given the Ad DBPs also carry such positively charged motifs in the
N-terminal region. OAV DBP has a KKRK sequence atrelative amounts of these proteins (Fig. 4) it seems un-
likely that they are contaminating cellular polypeptides. residues 11–14 of its ORF (Fig. 10) which may serve a
similar purpose. The limited homology between OAVThe roles of these proteins in virus structure and the
identity of their coding sequences are unknown. There DBP and the other Ad proteins may identify residues
which are critical for function. DBP is a zinc-binding pro-are no continuous ORFs on either strand of the genome
which could code for proteins of this size as 1 kb of tein (Eagle and Klessig, 1992). However, the first Cys in
the motif HXCX8CXH (Ad2 residues 273–286) which wascoding sequence would be required. Splicing of smaller
ORFs may occur but an alternative explanation is that thought to be involved in zinc binding (Eagle and Klessig,
1992) is not conserved in OAV. Structural studies (Tuckerproteins which are presently considered nonstructural
may in fact be structural polypeptides in OAV. Attempts et al., 1994) have shown that Cys284 and His286 together
with Cys339 and Cys355 (Ad2 numbering) are involvedare being made to obtain peptide sequence data for
proteins 5 and 6 in order to identify their coding se- in binding one atom of zinc. A second atom is bound by
Cys residues 396, 398, 450, and 467 (Tucker et al., 1994).quences.
All of these residues are conserved in the OAV protein
(Fig. 10). In OAV there are several changes in the 10 GlyDNA-binding protein
residues which are conserved in other Ad DBPs. Ad2
residues Gly280 and 362, which are involved in tight b-The ORF for OAV DBP is located in the same relative
position in the genome as in human Ads, i.e., on the turns, are Pro and Glu, respectively, in OAV. The former
maintains a turn but is coupled with a 2-residue deletion.complementary strand between ORFs for the viral pro-
teinase and 100K hexon assembly protein (Fig. 1). In Gly280 and Leu282 are also altered in ts mutants and this
region together with the zinc-binding domain appearsother Ads, DBP transcripts are initiated from the E2A
promoter which is located upstream of the ORF, but all critical for stability of the protein (Tucker et al., 1994).
Gly267, 287, and 356, the latter two being adjacent toof the coding sequences are contained in the major ORF.
The E2A promoter has not been mapped in OAV, but if zinc-binding residues, are all conserved. However, of 5
glycines that are adjacent to positively charged residues,all the DBP coding sequences are in the ORF, it is pre-
dicted to be the shortest described so far, being 157 only 2 (245 and 409) are maintained in OAV. These were
suggested to be necessary to allow a good interactionand 91 residues shorter than that for Ad2 and Ad40,
respectively (Table 2). The predicted size agrees well with the DNA (Tucker et al., 1994).
The C-terminus of OAV DBP is about 28 residueswith the apparent size of a prominent 44-kDa polypeptide
which is detected in OAV-infected CSL503 cells at 24 hr longer than other DBPs and contains many charged
amino acids (Fig. 10). This is a significant difference asp.i. after radiolabeling with [35S]methionine and -cysteine
(data not shown). As OAV DBP contains a high level of an insertion of 22 residues at the C-terminus of Ad5 (or
Ad2) DBP destroyed the ability of that virus to replicateCys and Met (15 and 16 residues, respectively), and as
this protein cannot be detected in purified radiolabeled (Vos et al., 1989). The C-terminus of Ad5 DBP (residues
513–529) is thought to be involved in numerous hy-virus preparations (A. Khatri, unpublished results), it is a
strong candidate to be DBP. drophobic interactions which may be involved in co-oper-
ative binding between DBP subunits (Tucker et al., 1994).DBP is a multifunctional polypeptide which is thought
to consist of two domains. The N-terminal domain (resi- The highly conserved residues Leu515, Pro516, Pro526,
and Phe527 are all conserved in OAV. Thus, the co-oper-dues 1–173 of Ad2) is poorly conserved between sero-
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FIG. 10. Comparison of OAV DNA-binding protein sequence with Ad12, Ad2, and Ad40 homologues. (l) Conserved Cys residues known to be
involved in metal binding (Tucker et al., 1994). Note the N-terminal truncation and C-terminal extension of the OAV protein.
ative binding mechanism proposed for Ad5 DBP may still transcripts probably terminate just prior to the fiber gene
be functional for OAV DBP, but it is not clear how the using the AATAAA signal near the 3* end of the E4 30.8-
extended, charged C-terminus is accommodated in the kDa ORF. The E3 and E4 regions therefore appear to be
structure. discrete transcriptional units separated by 1 kb of A/
T-rich sequences, but their promoters are still to be
OAV E4 and E3 regions mapped. Candidate TATA boxes (TATAAT and TATAAA)
for the E4 promoter are present near bases 25,640 andTranscripts on the left to right strand of the OAV ge-
25,800, respectively. However, for E3 no such elementsnome terminate soon after the fiber gene (Vrati et al.,
exist upstream of the Met of the 5* 12.9-kDa ORF. As RT-1995) and the sequence shows that there are no other
PCR experiments suggest that this region of the genomesignificant ORFs downstream. Thus, sequences down-
is transcribed (S. Vrati, unpublished results), the pro-stream of the fiber gene probably code only for the pro-
moter may form part of the ITR in this compact genome.posed E4 and E3 regions as shown in Figs. 1, 11A, and
The protein products derived from the E3/E4 regions11B. A detailed transcription map of this portion of the
have not yet been investigated. The assignment of E4 isgenome remains to be determined. However, the termi-
based upon homology which was detected betweennation points for the E3 RNA transcripts was experimen-
18.8- and 30.8-kDa reading frames of OAV and the E4tally determined by RT-PCR mapping, cloning, and se-
34-kDa protein homologues from human Ad2, 12, andquencing as previously described (Vrati et al., 1995). Left-
40 and murine Ad type 1 (Fig. 12). Low-level homologyward E3 transcripts terminate at base 20,438 (end of
the 20.5-kDa ORF), prior to the A/T-rich sequence. E4 between murine Ad and human Ad2 was noted pre-
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cant hydrophobic or membrane-spanning sequences
that might suggest functional homology with other Ad
proteins such as the 19- and 6.7-kDa glycoproteins which
have been described for Ad2 E3 (Wold and Gooding,
1991; Wilson-Rawls and Wold, 1993).
The location of the proposed E3 and E4 regions and
their separation by an 1 kb A/T-rich region is unprece-
dented in adenovirus genomes. This A/T-rich sequence
has a 70.2% A/T content between bases 25,627 and
26,642 and is frequently punctuated on both strands by
termination codons, making it very unlikely that it codes
for any protein, unless complex splicing occurs. Whether
this region is transcribed into mRNA has not been investi-
gated, although it is not the site at which the VA RNA
gene(s) are located (A. Venktesh and G.W.B., unpub-
lished results). Considering the otherwise compact na-
FIG. 11. Summary of the OAV genome structure in the proposed (A) ture of the genome, the A/T-rich region is a peculiarity
E4 and (B) E3 regions. Features are as described for Fig. 2.
and its function, if any, remains unclear.
viously (Ball et al., 1991; Kring et al., 1992). The similarity Summary
between the 34-kDa homologues is largely restricted to
the sequence HCHCXXPGSLQC, but as this motif is con- The genome of OAV287 is the smallest adenovirus
genome characterized to date. It is clear that there areserved between Ads of diverse origin (Fig. 12) and was
not found in any other protein in the databases, it appears many similarities in genome structure between human
and animal Ads and OAV. However, there also significantto be significant. Apart from this motif, the OAV 18.8- and
30.8-kDa ORFs are different from those in the other Ads differences. The apparent absence of proteins V and IX
and the presence of at least one new gene (for p28K)and also very different from each other in length and
sequence. Perhaps the repetition of this motif reflects are unique to OAV. The absence of an E3 region between
the pVIII and fiber genes and the presence of an unchar-functional redundancy in the E4 region similar to that
which occurs in human Ad genomes (Bridge and Ketner, acterized group of reading frames at the right-hand end
of the genome are also distinctive. Low-level homology1989; Huang and Hearing, 1989).
The identity of the E3 region is also tentative and sup- in the E1 region also marks this virus as unusual. Despite
the presence of the A/T-rich sequence and proposed E4/ported only by the nonessential nature of at least one
reading frame, as described in the accompanying paper E3 regions which, in the complexity of their ORFs, appear
to match human Ads, the OAV genome is considerably(Vrati et al., 1996b). The transcripts and protein products
from this region remain to be elucidated but, as in other shorter than human Ad genomes (29.5 vs 36 kb). This is
achieved by truncation of genes across the whole ge-E3 regions, some ORFs appear capable of coding for
discrete protein products as they have Met codons near nome. Compared with Ad2, the E1A/B region is 1 kb
shorter in OAV while the IVa2, DNA pol, and pTP regionsthe 5* end (Fig. 11B). However, there is no detectable
homology between OAV ORFs and other Ad proteins. are similar in size as are the fiber genes and E3 regions.
OAV E4 is about 0.9 kb shorter than Ad2. The majorSearches also failed to reveal the presence of any signifi-
FIG. 12. Alignment of E4 34K homologues from human Ad 2, 12, and 40; mouse Ad; and OAV 18.8- and 30.8-kDa ORFs.
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adenovirus pVII protein—functional implications. Virology 193, 986–difference lies in the region extending from the 52/55K
988.protein to the end of pVIII. This is about 4 kb shorter in
Chiou, S. K., Tseng, C. C., Rao, L., and White, E. (1994). FunctionalOAV, partly because it lacks the 1-kb ORF for protein complementation of the adenovirus E1B 19-kilodalton protein in the
V. Many other OAV genes are generally shorter, which inhibition of apoptosis in infected cells. J. Virol. 68, 6553–6566.
accounts for the remainder of the shortfall. OAV and hu- Cleghon, V., Voelkerding, K., Morin, N., Delsert, C., and Klessig, D. F.
(1989). Isolation and characterization of a viable adenovirus mutantman Ad viruses are likely to be serologically distinct al-
defective in nuclear transport of the DNA-binding protein. J. Virol. 63,though their icosahedral capsids may have a similar size.
2289–2299.Given its smaller genome size, its possibly greater pack-
Crompton, J., Toogood, C. I. A., Wallis, N., and Hay, R. T. (1994). Expres-
aging capacity, and the low-level homology between OAV sion of a foreign epitope on the surface of the adenovirus hexon. J.
and human Ad genomes (reducing the chance of possi- Gen. Virol. 75, 133–139.
Culp, J. S., Webster, L. C., Friedman, D. J., Smith, C. L., Huang, W. J.,ble recombination events), OAV might offer advantages
Wu, F. Y., Rosenberg, M., and Ricciardi, R. P. (1988). The 289-aminoas a vector for gene delivery provided it can enter appro-
acid E1A protein of adenovirus binds zinc in a region that is importantpriate cell types. This is under investigation.
for trans-activation. Proc. Natl. Acad. Sci. USA 85, 6450–6454.
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